ArriVent BioPharma (AVBP) Earnings Date & Reports

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AVBP is expected to report earnings to rise 21.67% to -73 cents per share on May 07

ArriVent BioPharma AVBP Stock Earnings Reports

Q1'25

Est.

$-0.73

Q4'24

Missed

by $0.14

Q3'24

Missed

by $0.07

Q2'24

Missed

by $0.14

The last earnings report on March 03 showed earnings per share of -60 cents, missing the estimate of -46 cents. With 14.13K shares outstanding, the current market capitalization sits at 763.32M.

View a ticker or compare two or three

Compare

AVBP